Hepatoprotective activity of Bombax ceiba linn against isoniazid and rifampicin-induced toxicity in experimental rats

International Journal of Applied Research in Natural Products

Volumn 3, Issue 3, 2010, Pages 19-26

  Ravi, V ^a   Patel, S S ^a   Verma, N K ^a   Dutta, D ^a   Saleem, T S M ^a  

^a HIMALAYAN PHARMACY INSTITUTE   (India)

Author keywords

Bombax ceiba; Hepatotoxicity; Isoniazid; Oxidative stress; Rifampicin

Indexed keywords

ANIMALIA; BOMBAX; BOMBAX CEIBA; CEIBA; RATTUS;

EID: 78649432084     PISSN: None     EISSN: 19406223     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Adhvaryu MR, Reddy N, Parabia MH. 2007. Effects of four Indian medicinal herbs on isoniazid-and pyrazinamideinduced hepatic injury and immunosuppression in guinea pigs. Word J Gastroenterol 13:3199-205.
2. Anon X. 1997. The resurgence of tuberculosis: a call for commitment. General policy topics WHO Drug Info 5:39-40.
3. Bahri AK, Chiang CS, Timbrel JA. 1981. Acetyl hydrazine hepatotoxicity. Toxicol Appl Pharmacol 60:561-9.
4. Buckingham J. 1992. Dictionary of natural products. Champan and Hall scientific data division. Landon. 3698 p.
5. Ellard GA, Gammon PT. 1976. Pharmacokinetics of isoniazid metabolism in man. J Pharmacokinat Biopharm 4:83-113.
6. Ellman GL. 1959. Tissue sulphydryl groups. Archives Biochem & Biophysics 82:70-77.
7. Garner P, Holmes A, Ziganahina L. 2004. Tuberculosis. Clin Evid 11:1081-1093.
8. Georgieva N, Gadjeva V, Tolekova A. 2004. New isonicotinoylhydrazones with ssa protect against oxidativehepatic injury of isoniazid. TJS 2:37-43.
9. Jiang Y, Ren-xiu P, Jing Y, Rui K, Juan L. 2004. CYP2E1 mediated isoniazid-induced hepatotoxicity in rats. Acta Pharmacol Sin 25:699-704.
10. Kalra BS, Aggarwal S, Khurana N, Gupta A. 2007. Effect of cimetidine on hepatotoxicity induced by isoniazidrifampicin combination in rabbits. Indian journal of gastroenterology 26:18-21.
11. Kaplowitz N. 2002. Drug-induced liver disorders: introduction and overview. In: Kaplowitz N, DeLeve LD, editors. Drug-induced liver disease. New York. p 1-13.
12. Noda A, Hsu KY, Noda H, Yamamoto Y, Kurozumi T. 1983. Is Isoniazid-hepatotoxicity induced by the metabolite, hydralazine? J UOEH 5:183-90.
13. Okhawa H, Qohishi N, Yagi K. 1979. Assay of lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351-358.
14. Parthasarathy R, Nivethetha M, Brindha P. 2007. Hepatoprotective activity of Caesalpinia bonducella seeds on paracetamol induced hepatotoxicity in male albino rats. Indian Drugs 44(5):401-404.
15. Peretti E, Karlaganis G, Lauterburg BH. 1987. Acetylating of Acetylhydrazine, the toxic metabolite of isoniazid, in humans: inhibition by concomitant administration of isoniazid. J Pharmacol Exp Ther 243:686-689.
16. Rajesh KG, Achyut NK, Geeta W, Murthy PS, Ramesh C, Vibha T. 2005. Nutritional and Hypoglycemic Effect of Fruit Pulp of Annona squamosa in Normal Healthy and Alloxan-Induced Diabetic Rabbits. Ann Nutr Metab 49:407-413.
17. Ramaiah SK, Apte U, Mehendale HIM. 2001. Cytochrome P4502E1 induction increases thioacetamide liver injury in diet-restricted rats. Drug Metab Dispos 29:1088-95.
18. Saleem R, Ahmad SI, Ahmad M, Faizi Z, Rehman S, Ali M, Faizi S. 2003. Hypotensive activity and toxicology of constituents from Bombax ceiba stem bark. Biol Pharm Bull 26:41-46.
19. Saleem TS, Christina AJM, Chidambaranathan N, Ravi V, Gauthaman K. 2008. Hepatoprotective activity of Annona squamosa Linn. On experimental animal model. International Journal of Applied Research in Natural Products 1:1-7.
20. Santhosh S, Sini TK, Anandan R, Mathew PT. 2006. Effect of chitosan supplementation on antitubercular drugsinduced hepatotoxicity in rats. Toxicology 219:53-9.
21. Sharma SK. 2004. Antitubercular drugs and hepatotoxicity. Infect Genet Evol 4:167-70.
22. Shishoo CJ, Shar SA, Rathod IS, Savale SS, Vora MJ. 2001. Impaired bioavailability of rifampicin in presence of isoniazid from fixed dose combination (FDC) formulation. Int J Pharm 228:53-67.
23. Skakun NP, Shmanko VV. 1985. Synergistic effect of rifampicin on hepatotoxicity of isoniazid. Antibiot Med Biotekhnol 30:185-9.
24. Steele MA, Burk RF, Des PRM. 1991. Toxic hepatitis with isoniazid and rifampicin: a meta-analysis. Chest 99:465-471.
25. Tasduq SA, Peerzada K, Koul S, Bhat R, Johri RK. 2005. Biochemical manifestations of anti-tuberculosis drugs induced hepatotoxicity and the effect of silymarin. Hepatol Res 31:132-135.
26. Thomas BS, Wong LT, Zeitz W, Solomonraj G. 1981. Isoniazid metabolism in the rabbit, and the effect of rifampin pretreatment. Res Commun Chem pathol Pharmacol 33:235-47.
27. Turner RA. 1965. Screening Methods in Pharmacology. Academic press. New York. 302-304 p.
28. Veerappan A, Miyasaki S, Kadarkaraisamy M, Ranganathan D. 2007. Acute and subacute toxicity studies of Aegle marmelos Corr. an Indian medicinal plant. Phytomedicine 14:209-215.
29. Vieira TO, Said A, Aboutabl E, Azzam M, Creczynski P, Tania B. 2009. Antioxidant activity of methanolic extract of Bombax ceiba. Redox Report 14(6):41-46.
30. Wu JW, Leev SD, Yeh PF. 1990. Isoniazid-Rifampicin induced hepatitis in hepatitis B carriers. Gastroentrology 98:502-4.
31. Yasuda K, Sato A, Chida K. 1990. Pulmonary tuberculosis with chemotherapy related liver dysfunction. Kekkadu 65:407-13.